000 | 01228 a2200325 4500 | ||
---|---|---|---|
005 | 20250517194315.0 | ||
264 | 0 | _c20181031 | |
008 | 201810s 0 0 eng d | ||
022 | _a1879-0852 | ||
024 | 7 |
_a10.1016/j.ejca.2017.12.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIbrahim, Sajida | |
245 | 0 | 0 |
_aPharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c03 2018 |
||
300 |
_a119-120 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 | _aCarcinoembryonic Antigen |
650 | 0 | 4 | _aColorectal Neoplasms |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRamucirumab |
700 | 1 | _aRaoul, William | |
700 | 1 | _aLecomte, Thierry | |
700 | 1 | _aPaintaud, Gilles | |
700 | 1 | _aTernant, David | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 92 _gp. 119-120 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2017.12.004 _zAvailable from publisher's website |
999 |
_c27975724 _d27975724 |